Table 6.
Association between anthropometric measurements and alpha-1-antitrypsin, myeloperoxidase, and neopterin at 9-month follow-up (N = 205)
| Outcome | % | Alpha-1- antitrypsin OR (95% CI)* | Myeloperoxidase OR (95% CI)* | Neopterin OR (95% CI)* | |||
|---|---|---|---|---|---|---|---|
| Age adjusted (Q1 vs. Q4) | Fully adjusted† (Q1 vs. Q4) | Age adjusted (Q1 vs. Q4) | Fully adjusted† (Q1 vs. Q4) | Age adjusted (Q1 vs. Q4) | Fully adjusted† (Q1 vs. Q4) | ||
| Proportion WAZ < −2 | 24 | 3.11 (1.18, 8.17) ‡ | 3.17 (1.19, 8.43)‡ | 1.93 (0.70, 5.37) | 1.92 (0.69, 5.32) | 2.07 (0.86, 5.00) | 2.17 (0.87, 5.38) |
| Proportion HAZ < −2 | 31 | 1.44 (0.62, 3.37) | 1.42 (0.59, 3.39) | 1.08 (0.44, 2.66) | 1.16 (0.46, 2.88) | 1.86 (0.83, 4.14) | 1.57 (0.69, 3.59) |
| Proportion WHZ < −2 | 7 | 6.66 (0.76, 58.12) | 7.41 (0.83, 66.49) | 2.98 (0.30, 30.08) | 3.21 (0.32, 32.35) | 2.02 (0.47, 8.66) | 1.91 (0.43, 8.56) |
CI = confidence interval; HAZ = length/height-for-age z-score; OR = odds ratio; WAZ = weight-for-age z-score; WHZ = weight-for-length/height z-score.
*
OR compares the first to the fourth quartile.
†
Fully adjusted models adjust for age, age squared, caregiver educational level, and family size.
‡
P value < 0.05.